All Stories

  1. Overdispersion Effects on Reliability Test Planning
  2. An EWMA sign chart for dispersion with exact run length properties
  3. Optimal repetitive reliability inspection of manufactured lots for lifetime models using prior information
  4. One-sided variable sampling interval EWMA control charts for monitoring the multivariate coefficient of variation in the presence of measurement errors
  5. Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population
  6. 1240P Prognostic impact of the CONtrolling NUTritional status (CONUT) score in patients with stage III non-small cell lung cancer (NSCLC)
  7. Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy
  8. An evaluation of the environmental factors for supply chain strategy decisions using grey systems and composite indicators
  9. Impact of Age on Inflammation-Based Scores among Patients Diagnosed with Stage III Non-Small Cell Lung Cancer
  10. An EWMA control chart for the multivariate coefficient of variation
  11. Mortality forecasting in Colombia from abridged life tables by sex
  12. Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis
  13. A MULTIDIMENSIONAL SCALING TO ASSESMENT INNOVATION COMPETENCY
  14. Bi-objective optimisation of a multihead weighing process
  15. Molecular subtyping of colon cancer (CC) based on mutational status of RAS, BRAF, and DNA mismatch repair (MMR) proteins. Prognostic value.
  16. A multiobjective approach for optimization of the multihead weighing process
  17. Optimal Design of Pre-control Plans
  18. A methodology based on profitability criteria for defining the partial defection of customers in non-contractual settings
  19. Phase II Trial of Concomitant Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine and Intensity-Modulated Radiotherapy (IMRT) in Rectal Cancer
  20. Phase II Trial of Oxaliplatin and Capecitabine After Progression to First-Line Chemotherapy in Androgen-Independent Prostate Cancer Patients
  21. Predicting the duration of chemotherapy-induced neutropenia: new scores and validation
  22. Experience with fulvestrant acetate in castration-resistant prostate cancer patients